Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Urinary Bladder"" wg kryterium: Temat


Tytuł :
A single-blind randomized control trial of trigonal versus nontrigonal Botulinum toxin-A injections for patients with urinary incontinence and poor bladder compliance secondary to spinal cord injury.
Autorzy :
Chen H; Department of Urology, Guangdong Provincial Work Injury Rehabilitation Hospital, Guangzhou, People's Republic of China.; Department of Urology, Qingyan City People's Hospital, Guangdong, People's Republic of China.
Xie K; Department of Urology, Guangzhou First Municipal People's Hospital, Guangzhou, People's Republic of China.
Jiang C; Department of Urology, Qingyan City People's Hospital, Guangdong, People's Republic of China.
Pokaż więcej
Źródło :
The journal of spinal cord medicine [J Spinal Cord Med] 2021 Sep; Vol. 44 (5), pp. 757-764. Date of Electronic Publication: 2020 Jan 31.
Typ publikacji :
Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Botulinum Toxins, Type A*/adverse effects
Neuromuscular Agents*/adverse effects
Spinal Cord Injuries*/complications
Spinal Cord Injuries*/drug therapy
Urinary Bladder, Neurogenic*
Urinary Bladder, Overactive*
Urinary Incontinence*/drug therapy
Urinary Incontinence*/etiology
Humans ; Quality of Life ; Single-Blind Method ; Treatment Outcome ; Urinary Bladder ; Urodynamics
Czasopismo naukowe
Tytuł :
Occult retained needle in an AirSeal port during robotic radical cystectomy.
Autorzy :
McClintock G; Department of Urology, Chris O'Brien Lifehouse, Sydney, New South Wales, Australia.
Fallot J; Department of Urology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.
Ahmadi N; Department of Urology, Chris O'Brien Lifehouse, Sydney, New South Wales, Australia.
Thanigasalam R; Department of Urology, Chris O'Brien Lifehouse, Sydney, New South Wales, Australia.; Department of Urology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.; Institute of Academic Surgery, The University of Sydney, Sydney, New South Wales, Australia.
Trompf L; Department of Biological Sciences, Macquarie University, Sydney, New South Wales, Australia.
Leslie S; Department of Urology, Chris O'Brien Lifehouse, Sydney, New South Wales, Australia.; Department of Urology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.; Institute of Academic Surgery, The University of Sydney, Sydney, New South Wales, Australia.
Pokaż więcej
Źródło :
ANZ journal of surgery [ANZ J Surg] 2021 Oct; Vol. 91 (10), pp. E680-E681. Date of Electronic Publication: 2021 Mar 02.
Typ publikacji :
Journal Article
MeSH Terms :
Robotic Surgical Procedures*
Robotics*
Urinary Bladder Neoplasms*/surgery
Cystectomy ; Humans ; Treatment Outcome ; Urinary Bladder
Czasopismo naukowe
Tytuł :
Robot-Assisted Laparoscopic Management of Bladder/Prostate Rhabdomyosarcoma in Children: Initial Series and 1-Year Outcomes.
Autorzy :
Li P; Department of Urology, Bayi Children's Hospital, Affiliated to The Seventh Medical Center of Chinese PLA General Hospital, Beijing, People's Republic of China.
Zhou H; Department of Urology, Bayi Children's Hospital, Affiliated to The Seventh Medical Center of Chinese PLA General Hospital, Beijing, People's Republic of China.; The Second School of Clinical Medicine, Southern Medical University, Guangzhou, People's Republic of China.; Medical School of Chinese PLA, Beijing, People's Republic of China.
Cao H; Department of Urology, Nanxi Shan Hospital of Guangxi Zhuang Autonomous Region, Guilin, People's Republic of China.
Xu B; Department of Pediatric Surgery, Xiamen Maternity and Child Health Hospital, Xiamen, People's Republic of China.
Guo T; Department of Urology, Bayi Children's Hospital, Affiliated to The Seventh Medical Center of Chinese PLA General Hospital, Beijing, People's Republic of China.; Medical School of Chinese PLA, Beijing, People's Republic of China.
Zhu W; Department of Urology, Bayi Children's Hospital, Affiliated to The Seventh Medical Center of Chinese PLA General Hospital, Beijing, People's Republic of China.; Medical School of Chinese PLA, Beijing, People's Republic of China.
Zhao Y; Department of Urology, Bayi Children's Hospital, Affiliated to The Seventh Medical Center of Chinese PLA General Hospital, Beijing, People's Republic of China.; Medical School of Chinese PLA, Beijing, People's Republic of China.
Zhuo R; Department of Urology, Bayi Children's Hospital, Affiliated to The Seventh Medical Center of Chinese PLA General Hospital, Beijing, People's Republic of China.; The Second School of Clinical Medicine, Southern Medical University, Guangzhou, People's Republic of China.
Ma L; Department of Urology, Bayi Children's Hospital, Affiliated to The Seventh Medical Center of Chinese PLA General Hospital, Beijing, People's Republic of China.
Zhou X; Department of Urology, Bayi Children's Hospital, Affiliated to The Seventh Medical Center of Chinese PLA General Hospital, Beijing, People's Republic of China.
Tao T; Department of Urology, Bayi Children's Hospital, Affiliated to The Seventh Medical Center of Chinese PLA General Hospital, Beijing, People's Republic of China.
Feng Z; Department of Urology, Bayi Children's Hospital, Affiliated to The Seventh Medical Center of Chinese PLA General Hospital, Beijing, People's Republic of China.
Pokaż więcej
Źródło :
Journal of endourology [J Endourol] 2021 Oct; Vol. 35 (10), pp. 1520-1525. Date of Electronic Publication: 2021 Sep 17.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Laparoscopy*
Rhabdomyosarcoma*/surgery
Robotics*
Urinary Bladder Neoplasms*/surgery
Child ; Cystectomy ; Humans ; Male ; Prostate ; Retrospective Studies ; Treatment Outcome ; Urinary Bladder
Czasopismo naukowe
Tytuł :
Influence of nutritional status and frailty phenotype on health-related quality of life of patients with bladder or kidney cancer.
Autorzy :
Dos Reis PF; Nutrition and Dietetic Service, Cancer Hospital Unit I, National Cancer Institute Jose Alencar Gomes da Silva, Rio de Janeiro, Brazil. .; Post-graduation Program in Medical Science, Rio de Janeiro State University, Rio de Janeiro, Brazil. .; Post-graduation Program in Food, Nutrition and Health, Rio de Janeiro State University, Rio de Janeiro, Brazil. .
de França PS; Nutrition and Dietetic Service, Cancer Hospital Unit I, National Cancer Institute Jose Alencar Gomes da Silva, Rio de Janeiro, Brazil.; Nutrition Institute, Rio de Janeiro State University, Rio de Janeiro, Brazil.
Dos Santos MP; Post-graduation Program in Food, Nutrition and Health, Rio de Janeiro State University, Rio de Janeiro, Brazil.
Martucci RB; Nutrition and Dietetic Service, Cancer Hospital Unit I, National Cancer Institute Jose Alencar Gomes da Silva, Rio de Janeiro, Brazil.; Nutrition Institute, Rio de Janeiro State University, Rio de Janeiro, Brazil.
Pokaż więcej
Źródło :
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer [Support Care Cancer] 2021 Sep; Vol. 29 (9), pp. 5139-5150. Date of Electronic Publication: 2021 Feb 19.
Typ publikacji :
Journal Article
MeSH Terms :
Frailty*/epidemiology
Kidney Neoplasms*/epidemiology
Malnutrition*/epidemiology
Urinary Bladder Neoplasms*/epidemiology
Aged ; Cross-Sectional Studies ; Female ; Humans ; Male ; Middle Aged ; Nutritional Status ; Quality of Life ; Urinary Bladder
Czasopismo naukowe
Tytuł :
Synchronous Bilateral Adrenal Gland Metastases of Bladder Carcinoma Revealed on 18F-FDG PET/CT.
Autorzy :
Erol Ö; From the Clinic of Nuclear Medicine.
Ergül N; From the Clinic of Nuclear Medicine.
Algün Gedik A; Clinic of Pathology, Istanbul Training and Research Hospital, Istanbul, Turkey.
Beyhan E; From the Clinic of Nuclear Medicine.
Çermik TF; From the Clinic of Nuclear Medicine.
Pokaż więcej
Źródło :
Clinical nuclear medicine [Clin Nucl Med] 2021 Sep 01; Vol. 46 (9), pp. e466-e468.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Adrenal Gland Neoplasms*/diagnostic imaging
Carcinoma, Transitional Cell*
Urinary Bladder Neoplasms*/diagnostic imaging
Adrenal Glands ; Aged, 80 and over ; Fluorodeoxyglucose F18 ; Humans ; Male ; Positron Emission Tomography Computed Tomography ; Urinary Bladder
Czasopismo naukowe
Tytuł :
A Single-arm Phase II Trial of Neoadjuvant Cabazitaxel and Cisplatin Chemotherapy for Muscle-Invasive Transitional Cell Carcinoma of the Urinary Bladder.
Autorzy :
Challapalli A; Department of Clinical Oncology, Bristol Cancer Institute, Bristol, UK.
Masson S; Department of Clinical Oncology, Bristol Cancer Institute, Bristol, UK.
White P; Department of Statistics, University of the West of England, Bristol, UK.
Dailami N; Department of Statistics, University of the West of England, Bristol, UK.
Pearson S; Department of Clinical Oncology, Bristol Cancer Institute, Bristol, UK.
Rowe E; Department of Urology, Bristol Urological Institute, North Bristol NHS Trust, Bristol, UK.
Koupparis A; Department of Urology, Bristol Urological Institute, North Bristol NHS Trust, Bristol, UK.
Oxley J; Department of Pathology, North Bristol NHS Trust, Bristol, UK.
Abdelaziz A; Department of Oncology, Ain Shams University Hospitals, Egypt.
Ash-Miles J; Department of Radiology, North Bristol NHS Trust, Bristol, UK.
Bravo A; Department of Clinical Oncology, Bristol Cancer Institute, Bristol, UK.
Foulstone E; Department of Clinical Oncology, Bristol Cancer Institute, Bristol, UK.
Perks C; IGFs & Metabolic Endocrinology Group, Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.
Holly J; IGFs & Metabolic Endocrinology Group, Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.
Persad R; Department of Urology, Bristol Urological Institute, North Bristol NHS Trust, Bristol, UK.
Bahl A; Department of Clinical Oncology, Bristol Cancer Institute, Bristol, UK. Electronic address: .
Pokaż więcej
Źródło :
Clinical genitourinary cancer [Clin Genitourin Cancer] 2021 Aug; Vol. 19 (4), pp. 325-332. Date of Electronic Publication: 2021 Feb 18.
Typ publikacji :
Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Carcinoma, Transitional Cell*/drug therapy
Carcinoma, Transitional Cell*/surgery
Urinary Bladder Neoplasms*/drug therapy
Urinary Bladder Neoplasms*/surgery
Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Chemotherapy, Adjuvant ; Cisplatin/adverse effects ; Cystectomy ; Disease-Free Survival ; Humans ; Muscles ; Neoadjuvant Therapy ; Taxoids ; Treatment Outcome ; Urinary Bladder
Czasopismo naukowe
Tytuł :
Pelvic lipomatosis associated with bilateral obstructive uropathy and proliferative cystitis.
Autorzy :
Flor JMS; Surgery, Philippine General Hospital, Manila, Philippines .
Gaston MJFV; Surgery, Philippine General Hospital, Manila, Philippines.
Lapitan MCM; Surgery, Philippine General Hospital, Manila, Philippines.
Pokaż więcej
Źródło :
BMJ case reports [BMJ Case Rep] 2021 Aug 17; Vol. 14 (8). Date of Electronic Publication: 2021 Aug 17.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Cystitis*
Hydronephrosis*/diagnostic imaging
Hydronephrosis*/etiology
Hydronephrosis*/surgery
Lipomatosis*/complications
Lipomatosis*/diagnostic imaging
Urinary Bladder Neoplasms*
Adult ; Humans ; Male ; Urinary Bladder Diseases
SCR Disease Name :
Pelvic lipomatosis
Czasopismo naukowe
Tytuł :
"Early-pull-out" technique for intracorporeal ileal conduit urinary diversion after robot-assisted radical cystectomy.
Autorzy :
Shin T
Mimata H
Pokaż więcej
Źródło :
International journal of urology : official journal of the Japanese Urological Association [Int J Urol] 2021 Jul; Vol. 28 (7), pp. 778-779. Date of Electronic Publication: 2021 Apr 08.
Typ publikacji :
Journal Article
MeSH Terms :
Robotic Surgical Procedures*
Robotics*
Urinary Bladder Neoplasms*/surgery
Urinary Diversion*
Cystectomy ; Humans ; Treatment Outcome ; Urinary Bladder/surgery
Czasopismo naukowe
Tytuł :
Immune Checkpoint Inhibition in Advanced Bladder and Kidney Cancer: Responses and Further Management.
Autorzy :
Parikh M; Division of Hematology Oncology, Department of Internal Medicine, UC Davis School of Medicine, Sacramento, CA.
Powles T; Barts Health NHS Trust and the Royal Free NHS Foundation Trust, Barts Cancer Institute, and Queen Mary University of London, London, United Kingdom.
Pokaż więcej
Źródło :
American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting [Am Soc Clin Oncol Educ Book] 2021 Jun; Vol. 41, pp. e182-e189.
Typ publikacji :
Journal Article
MeSH Terms :
Kidney Neoplasms*/drug therapy
Urinary Bladder Neoplasms*/drug therapy
Immune Checkpoint Inhibitors/*therapeutic use
Carcinoma, Renal Cell/drug therapy ; Humans ; Nivolumab/therapeutic use ; Urinary Bladder
Czasopismo naukowe
Tytuł :
Progression of Disease after Bacillus Calmette-Guérin Therapy: Refining Patient Selection for Neoadjuvant Chemotherapy before Radical Cystectomy.
Autorzy :
Hensley PJ; Department of Urology, University of Texas MD Anderson Cancer Center, Houston, Texas.
Bree KK; Department of Urology, University of Texas MD Anderson Cancer Center, Houston, Texas.
Campbell MT; Department of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas.
Alhalabi O; Department of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas.
Kokorovic A; Department of Urology, University of Texas MD Anderson Cancer Center, Houston, Texas.
Miest T; Department of Urology, University of Texas MD Anderson Cancer Center, Houston, Texas.
Nogueras-Gonzalez GM; Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, Texas.
Gao J; Department of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas.
Siefker-Radtke AO; Department of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas.
Guo CC; Department of Pathology, University of Texas MD Anderson Cancer Center,Houston, Texas.
Navai N; Department of Urology, University of Texas MD Anderson Cancer Center, Houston, Texas.
Dinney CP; Department of Urology, University of Texas MD Anderson Cancer Center, Houston, Texas.
Kamat AM; Department of Urology, University of Texas MD Anderson Cancer Center, Houston, Texas.
Pokaż więcej
Źródło :
The Journal of urology [J Urol] 2021 Nov; Vol. 206 (5), pp. 1258-1267. Date of Electronic Publication: 2021 Jun 29.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Cystectomy*
BCG Vaccine/*administration & dosage
Neoadjuvant Therapy/*methods
Neoplasm Recurrence, Local/*epidemiology
Urinary Bladder Neoplasms/*therapy
Aged ; Chemotherapy, Adjuvant/methods ; Chemotherapy, Adjuvant/statistics & numerical data ; Disease Progression ; Disease-Free Survival ; Female ; Humans ; Male ; Middle Aged ; Neoplasm Invasiveness ; Neoplasm Recurrence, Local/prevention & control ; Neoplasm Staging ; Patient Selection ; Retrospective Studies ; Risk Assessment/statistics & numerical data ; Risk Factors ; Urinary Bladder/drug effects ; Urinary Bladder/pathology ; Urinary Bladder/surgery ; Urinary Bladder Neoplasms/diagnosis ; Urinary Bladder Neoplasms/mortality ; Urinary Bladder Neoplasms/pathology
Czasopismo naukowe
Tytuł :
Prognostic Impact of Preoperative Plasma Levels of Urokinase Plasminogen Activator Proteins on Disease Outcomes after Radical Cystectomy.
Autorzy :
Schuettfort VM; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.; Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Pradere B; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
D'Andrea D; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
Grossmann NC; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.; Department of Urology, University Hospital Zurich, Zurich, Switzerland.
Quhal F; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.; Department of Urology, King Fahad Specialist Hospital, Dammam, Saudi Arabia.
Mostafaei H; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.; Research Center for Evidence Based Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
Laukhtina E; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.; Institute for Urology and Reproductive Health, Sechenov University, Moscow, Russia.
Mori K; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan.
Rink M; Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Karakiewicz PI; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Canada.
Motlagh RS; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.; Men's Health and Reproductive Health Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Katayama S; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.; Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
Lotan Y; Department of Urology, University of Texas Southwestern, Dallas, Texas.
Scherr D; Department of Urology, Weill Cornell Medical College, New York Presbyterian Hospital, New York, New York.
Abufaraj M; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.; Division of Urology, Department of Special Surgery, Jordan University Hospital, The University of Jordan, Amman, Jordan.
Fajkovica H; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
Compérat E; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
Enikeev D; Institute for Urology and Reproductive Health, Sechenov University, Moscow, Russia.
Shariat SF; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.; Institute for Urology and Reproductive Health, Sechenov University, Moscow, Russia.; Department of Urology, University of Texas Southwestern, Dallas, Texas.; Department of Urology, Weill Cornell Medical College, New York Presbyterian Hospital, New York, New York.; Division of Urology, Department of Special Surgery, Jordan University Hospital, The University of Jordan, Amman, Jordan.; Karl Landsteiner Institute of Urology and Andrology, Vienna, Austria.; European Association of Urology Research Foundation, Arnhem, Netherlands.
Pokaż więcej
Źródło :
The Journal of urology [J Urol] 2021 Nov; Vol. 206 (5), pp. 1122-1131. Date of Electronic Publication: 2021 Jun 28.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Cystectomy*
Biomarkers, Tumor/*blood
Carcinoma, Transitional Cell/*surgery
Neoplasm Recurrence, Local/*epidemiology
Urinary Bladder Neoplasms/*surgery
Aged ; Carcinoma, Transitional Cell/blood ; Carcinoma, Transitional Cell/diagnosis ; Carcinoma, Transitional Cell/mortality ; Disease-Free Survival ; Female ; Follow-Up Studies ; Humans ; Lymphatic Metastasis ; Male ; Neoplasm Staging ; Plasminogen Activator Inhibitor 1/blood ; Preoperative Period ; Prognosis ; Receptors, Urokinase Plasminogen Activator/blood ; Retrospective Studies ; Risk Assessment/statistics & numerical data ; Urinary Bladder/pathology ; Urinary Bladder/surgery ; Urinary Bladder Neoplasms/blood ; Urinary Bladder Neoplasms/diagnosis ; Urinary Bladder Neoplasms/mortality ; Urokinase-Type Plasminogen Activator/blood
Czasopismo naukowe
Tytuł :
Urothelial carcinoma in COVID-19: lessons from a pandemic and their impact on clinical practice.
Autorzy :
Tayeh GA; Department of Urology, Hotel Dieu de France Hospital, Beirut, Lebanon.
Khalil N; Department of Urology, Hotel Dieu de France Hospital, Beirut, Lebanon.
Alkassis M; Department of Urology, Hotel Dieu de France Hospital, Beirut, Lebanon.
Aoun F; Department of Urology, Hotel Dieu de France Hospital, Beirut, Lebanon.
Waked C; Department of Urology, Hotel Dieu de France Hospital, Beirut, Lebanon.
Nemr E; Department of Urology, Hotel Dieu de France Hospital, Beirut, Lebanon.
Pokaż więcej
Źródło :
Future oncology (London, England) [Future Oncol] 2021 Nov; Vol. 17 (32), pp. 4233-4235. Date of Electronic Publication: 2021 Oct 21.
Typ publikacji :
Editorial
MeSH Terms :
Cystectomy*
Cystoscopy*
Time-to-Treatment*
Urinary Bladder Neoplasms/*diagnosis
Urinary Bladder Neoplasms/*surgery
COVID-19/prevention & control ; Humans ; Primary Prevention/methods ; SARS-CoV-2 ; Urinary Bladder/pathology ; Urinary Bladder Neoplasms/pathology ; Urothelium/pathology
Opinia redakcyjna
Tytuł :
A Contemporary Analysis of Urethral Recurrence following Radical Cystectomy.
Autorzy :
Khanna A; Department of Urology, Mayo Clinic, Rochester, Minnesota.
Zganjar A; Department of Urology, Mayo Clinic, Rochester, Minnesota.
Lyon T; Department of Urology, Mayo Clinic, Jacksonville, Florida.
Shah P; Department of Urology, Mayo Clinic, Rochester, Minnesota.
Tollefson MK; Department of Urology, Mayo Clinic, Rochester, Minnesota.
Karnes RJ; Department of Urology, Mayo Clinic, Rochester, Minnesota.
Tarrell R; Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota.
Thapa P; Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota.
Thompson RH; Department of Urology, Mayo Clinic, Rochester, Minnesota.
Frank I; Department of Urology, Mayo Clinic, Rochester, Minnesota.
Boorjian SA; Department of Urology, Mayo Clinic, Rochester, Minnesota.
Pokaż więcej
Źródło :
The Journal of urology [J Urol] 2021 Oct; Vol. 206 (4), pp. 970-977. Date of Electronic Publication: 2021 May 25.
Typ publikacji :
Journal Article
MeSH Terms :
Cystectomy*
Carcinoma, Transitional Cell/*epidemiology
Urethral Neoplasms/*epidemiology
Urinary Bladder Neoplasms/*surgery
Aged ; Carcinoma, Transitional Cell/secondary ; Disease-Free Survival ; Female ; Humans ; Kaplan-Meier Estimate ; Male ; Middle Aged ; Prospective Studies ; Retrospective Studies ; Risk Factors ; Urethra/pathology ; Urethral Neoplasms/secondary ; Urinary Bladder/pathology ; Urinary Bladder/surgery ; Urinary Bladder Neoplasms/mortality ; Urinary Bladder Neoplasms/pathology
Czasopismo naukowe
Tytuł :
Urinary Molecular Pathology for Patients with Newly Diagnosed Urothelial Bladder Cancer.
Autorzy :
Zhang R; Department of Urology, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Zang J; State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Xie F; Huidu Shanghai Medical Sciences Ltd, Shanghai, China.
Zhang Y; Huidu Shanghai Medical Sciences Ltd, Shanghai, China.
Wang Y; Department of Urology, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Jing Y; State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Zhang Y; Shanghai Key Laboratory of Gynecologic Oncology, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Chen Z; CAS Key Laboratory of Computational Biology, CAS-MPG Partner Institute for Computational Biology, Shanghai Institute of Nutrition and Health, Chinese Academy of Sciences, Shanghai, China.; Peking-Tsinghua Center for Life Sciences, Academy for Advanced Interdisciplinary Studies, Center for Quantitative Biology, Peking University, Beijing, China.
Shahatiaili A; Department of Urology, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Cai MC; State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Zhao Z; Huidu Shanghai Medical Sciences Ltd, Shanghai, China.
Du P; Huidu Shanghai Medical Sciences Ltd, Shanghai, China.
Jia S; Huidu Shanghai Medical Sciences Ltd, Shanghai, China.
Zhuang G; Department of Urology, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.; State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Chen H; Department of Urology, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Pokaż więcej
Źródło :
The Journal of urology [J Urol] 2021 Oct; Vol. 206 (4), pp. 873-884. Date of Electronic Publication: 2021 Jun 01.
Typ publikacji :
Comparative Study; Journal Article; Observational Study; Validation Study
MeSH Terms :
Biomarkers, Tumor/*urine
Carcinoma, Transitional Cell/*diagnosis
Circulating Tumor DNA/*urine
Genotyping Techniques/*methods
Urinary Bladder Neoplasms/*diagnosis
Adult ; Aged ; Aged, 80 and over ; Biomarkers, Tumor/blood ; Biomarkers, Tumor/genetics ; Carcinoma, Transitional Cell/blood ; Carcinoma, Transitional Cell/genetics ; Carcinoma, Transitional Cell/urine ; Circulating Tumor DNA/blood ; Circulating Tumor DNA/genetics ; Female ; Gene Frequency ; High-Throughput Nucleotide Sequencing ; Humans ; Liquid Biopsy/methods ; Male ; Middle Aged ; Mutation ; Neoplasm Recurrence, Local ; Urinary Bladder/pathology ; Urinary Bladder Neoplasms/blood ; Urinary Bladder Neoplasms/genetics ; Urinary Bladder Neoplasms/urine
Czasopismo naukowe
Tytuł :
Risk Factors for Intravesical Recurrence after Minimally Invasive Nephroureterectomy for Upper Tract Urothelial Cancer (ROBUUST Collaboration).
Autorzy :
Katims AB; Department of Urology, Icahn School of Medicine at Mount Sinai, New York, New York.
Say R; Department of Urology, Icahn School of Medicine at Mount Sinai, New York, New York.
Derweesh I; Department of Urology, University of California San Diego School of Medicine, La Jolla, California.
Uzzo R; Department of Urological Oncology, Fox Chase Cancer Center, Temple University School of Medicine, Philadelphia, Pennsylvania.
Minervini A; Department of Urology, University of Florence, Florence, Italy.
Wu Z; Department of Urology, Changzheng Hospital, Second Military (Naval) Medical University, Shanghai, China.
Abdollah F; Vattikuti Urology Institute, Henry Ford Hospital, Detroit, Michigan.
Sundaram C; Department of Urology, Indiana University School of Medicine, Indianapolis, Indiana.
Ferro M; Division of Urology, European Institute of Oncology, Milan, Italy.
Rha K; Urological Science Institute, Yonsei University College of Medicine, Seoul, Korea.
Mottrie A; Department of Urology, Onze Lieve Vrouw Hospital, Aalst, Belgium.
Rosiello G; Department of Urology, Onze Lieve Vrouw Hospital, Aalst, Belgium.
Simone G; Department of Urology, Regina Elena National Cancer Institute, Rome, Italy.
Eun DD; Department of Urology, Temple University School of Medicine, Philadelphia, Pennsylvania.
Reese A; Department of Urology, Temple University School of Medicine, Philadelphia, Pennsylvania.
Kidd LC; Department of Urology, Temple University School of Medicine, Philadelphia, Pennsylvania.
Porter J; Swedish Urology Group, Seattle, Washington.
Bhattu AS; Department of Urology, University of Miami Miller School of Medicine, Miami, Florida.
Gonzalgo ML; Department of Urology, University of Miami Miller School of Medicine, Miami, Florida.
Margulis V; Department of Urology, University of Texas Southwestern Medical Center, Dallas, Texas.
Marcus J; Vattikuti Urology Institute, Henry Ford Hospital, Detroit, Michigan.
Danno A; Vattikuti Urology Institute, Henry Ford Hospital, Detroit, Michigan.
Meagher M; Department of Urology, University of California San Diego School of Medicine, La Jolla, California.
Tellini R; Department of Urological Oncology, Fox Chase Cancer Center, Temple University School of Medicine, Philadelphia, Pennsylvania.
Mari A; Department of Urological Oncology, Fox Chase Cancer Center, Temple University School of Medicine, Philadelphia, Pennsylvania.
Veccia A; Division of Urology, VCU Health System, Richmond, Virginia.
Ghoreifi A; Institute of Urology & Catherine and Joseph Aresty Department of Urology, Keck School of Medicine, University of Southern California, Los Angeles, California.
Autorino R; Division of Urology, VCU Health System, Richmond, Virginia.
Djaladat H; Institute of Urology & Catherine and Joseph Aresty Department of Urology, Keck School of Medicine, University of Southern California, Los Angeles, California.
Mehrazin R; Department of Urology, Icahn School of Medicine at Mount Sinai, New York, New York.
Pokaż więcej
Źródło :
The Journal of urology [J Urol] 2021 Sep; Vol. 206 (3), pp. 568-576. Date of Electronic Publication: 2021 Apr 21.
Typ publikacji :
Journal Article; Multicenter Study
MeSH Terms :
Carcinoma, Transitional Cell/*epidemiology
Kidney Neoplasms/*surgery
Nephroureterectomy/*adverse effects
Robotic Surgical Procedures/*adverse effects
Ureteral Neoplasms/*surgery
Urinary Bladder Neoplasms/*epidemiology
Aged ; Biopsy/adverse effects ; Biopsy/methods ; Carcinoma, Transitional Cell/diagnosis ; Carcinoma, Transitional Cell/secondary ; Carcinoma, Transitional Cell/surgery ; Disease-Free Survival ; Female ; Follow-Up Studies ; Humans ; Kidney/pathology ; Kidney/surgery ; Kidney Neoplasms/diagnosis ; Kidney Neoplasms/mortality ; Male ; Margins of Excision ; Middle Aged ; Neoplasm Seeding ; Nephroureterectomy/methods ; Proportional Hazards Models ; Retrospective Studies ; Risk Factors ; Ureter/pathology ; Ureter/surgery ; Ureteral Neoplasms/diagnosis ; Ureteral Neoplasms/mortality ; Ureteroscopy/adverse effects ; Urinary Bladder/pathology ; Urinary Bladder Neoplasms/diagnosis ; Urinary Bladder Neoplasms/secondary
Czasopismo naukowe
Tytuł :
Contemporary Rates of Gynecologic Organ Involvement in Females with Muscle Invasive Bladder Cancer: A Retrospective Review of Women Undergoing Radical Cystectomy following Neoadjuvant Chemotherapy.
Autorzy :
Bree KK; Department of Urology, University of Texas MD Anderson Cancer Center, Houston, Texas.
Hensley PJ; Department of Urology, University of Texas MD Anderson Cancer Center, Houston, Texas.
Westerman ME; Department of Urology, University of Texas MD Anderson Cancer Center, Houston, Texas.
Kokorovic A; Department of Urology, University of Texas MD Anderson Cancer Center, Houston, Texas.
Nogueras-Gonzalez GM; Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, Texas.
Dinney CP; Department of Urology, University of Texas MD Anderson Cancer Center, Houston, Texas.
Kamat AM; Department of Urology, University of Texas MD Anderson Cancer Center, Houston, Texas.
Navai N; Department of Urology, University of Texas MD Anderson Cancer Center, Houston, Texas.
Pokaż więcej
Źródło :
The Journal of urology [J Urol] 2021 Sep; Vol. 206 (3), pp. 577-585. Date of Electronic Publication: 2021 Apr 19.
Typ publikacji :
Journal Article
MeSH Terms :
Cystectomy*
Neoadjuvant Therapy*
Genital Neoplasms, Female/*epidemiology
Neoplasm Recurrence, Local/*epidemiology
Urinary Bladder Neoplasms/*pathology
Aged ; Chemotherapy, Adjuvant ; Female ; Follow-Up Studies ; Genital Neoplasms, Female/secondary ; Humans ; Hysterectomy ; Middle Aged ; Neoplasm Recurrence, Local/prevention & control ; Retrospective Studies ; Urinary Bladder/pathology ; Urinary Bladder/surgery ; Urinary Bladder Neoplasms/therapy ; Uterus/pathology ; Uterus/surgery ; Vagina/pathology ; Vagina/surgery
Czasopismo naukowe
Tytuł :
Expression Analysis of Same-Patient Metachronous and Synchronous Upper Tract and Bladder Urothelial Carcinoma.
Autorzy :
Petros FG; Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Currently at Department of Urology, The University of Toledo Medical Center, Toledo, Ohio.
Choi W; Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Currently at Johns Hopkins Greenberg Bladder Cancer Institute, Johns Hopkins University, Baltimore, Maryland.
Qi Y; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Moss T; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Currently at Viracor Eurofins Clinical Diagnostics, Lee's Summit, Missouri.
Li R; Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Currently at Department of Urology, Moffitt Cancer Center, Tampa, Florida.
Su X; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Guo CC; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Czerniak B; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Dinney C; Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
McConkey DJ; Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Currently at Johns Hopkins Greenberg Bladder Cancer Institute, Johns Hopkins University, Baltimore, Maryland.
Matin SF; Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Pokaż więcej
Źródło :
The Journal of urology [J Urol] 2021 Sep; Vol. 206 (3), pp. 548-557. Date of Electronic Publication: 2021 Apr 21.
Typ publikacji :
Comparative Study; Journal Article; Research Support, N.I.H., Extramural
MeSH Terms :
Carcinoma, Transitional Cell/*diagnosis
Kidney Neoplasms/*diagnosis
Neoplasms, Multiple Primary/*diagnosis
Neoplasms, Second Primary/*diagnosis
Ureteral Neoplasms/*diagnosis
Urinary Bladder Neoplasms/*diagnosis
Aged ; Biomarkers, Tumor/genetics ; Carcinoma, Transitional Cell/genetics ; Carcinoma, Transitional Cell/immunology ; Carcinoma, Transitional Cell/surgery ; Female ; Gene Expression Regulation, Neoplastic/immunology ; Humans ; Kidney/immunology ; Kidney/pathology ; Kidney/surgery ; Kidney Neoplasms/genetics ; Kidney Neoplasms/immunology ; Kidney Neoplasms/surgery ; Male ; Neoplasms, Multiple Primary/genetics ; Neoplasms, Multiple Primary/immunology ; Neoplasms, Multiple Primary/surgery ; Neoplasms, Second Primary/genetics ; Neoplasms, Second Primary/immunology ; Neoplasms, Second Primary/surgery ; RNA-Seq ; Tumor Microenvironment/genetics ; Tumor Microenvironment/immunology ; Ureter/immunology ; Ureter/pathology ; Ureter/surgery ; Ureteral Neoplasms/genetics ; Ureteral Neoplasms/immunology ; Ureteral Neoplasms/surgery ; Urinary Bladder/immunology ; Urinary Bladder/pathology ; Urinary Bladder/surgery ; Urinary Bladder Neoplasms/genetics ; Urinary Bladder Neoplasms/immunology ; Urinary Bladder Neoplasms/surgery
Czasopismo naukowe
Tytuł :
The Impact of Upper Tract Urothelial Carcinoma Diagnostic Modality on Intravesical Recurrence after Radical Nephroureterectomy: A Single Institution Series and Updated Meta-Analysis.
Autorzy :
Sharma V; Department of Urology, Mayo Clinic, Rochester, Minnesota.; Department of Urology, University of California, Los Angeles, California.; Greater Los Angeles VA, Health Services Research and Development Program, Los Angeles, California.
Miest TS; Department of Urology, MD Anderson Cancer Center, Houston, Texas.
Juvet TS; Department of Urology, Mayo Clinic, Rochester, Minnesota.
Toussi A; Department of Urology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
Packiam V; Department of Urology, University of Iowa Medical Center, Iowa City, Iowa.
Chamie K; Department of Urology, University of California, Los Angeles, California.
Matin SF; Department of Urology, MD Anderson Cancer Center, Houston, Texas.
Boorjian SA; Department of Urology, Mayo Clinic, Rochester, Minnesota.
Thompson RH; Department of Urology, Mayo Clinic, Rochester, Minnesota.
Frank I; Department of Urology, Mayo Clinic, Rochester, Minnesota.
Tollefson MK; Department of Urology, Mayo Clinic, Rochester, Minnesota.
Potretzke AM; Department of Urology, Mayo Clinic, Rochester, Minnesota.
Pokaż więcej
Źródło :
The Journal of urology [J Urol] 2021 Sep; Vol. 206 (3), pp. 558-567. Date of Electronic Publication: 2021 Apr 28.
Typ publikacji :
Journal Article; Meta-Analysis
MeSH Terms :
Carcinoma, Transitional Cell/*epidemiology
Kidney Neoplasms/*surgery
Nephroureterectomy/*adverse effects
Ureteral Neoplasms/*surgery
Urinary Bladder Neoplasms/*epidemiology
Aged ; Biopsy/adverse effects ; Biopsy/methods ; Biopsy/statistics & numerical data ; Carcinoma, Transitional Cell/diagnosis ; Carcinoma, Transitional Cell/secondary ; Carcinoma, Transitional Cell/surgery ; Female ; Follow-Up Studies ; Humans ; Kidney Neoplasms/diagnosis ; Kidney Neoplasms/pathology ; Male ; Neoplasm Seeding ; Proportional Hazards Models ; Retrospective Studies ; Ureteral Neoplasms/diagnosis ; Ureteral Neoplasms/pathology ; Ureteroscopy/adverse effects ; Ureteroscopy/statistics & numerical data ; Urinary Bladder/pathology ; Urinary Bladder Neoplasms/diagnosis ; Urinary Bladder Neoplasms/secondary
Czasopismo naukowe
Tytuł :
Disparities in male versus female oncologic outcomes following bladder preservation: A population-based cohort study.
Autorzy :
Ballas LK; Department of Radiation Oncology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
Navarro S; Department of Preventative Medicine, Keck School of Medicine, University of Southern CA, Los Angeles, CA, USA.
Luo C; Department of Preventative Medicine, Keck School of Medicine, University of Southern CA, Los Angeles, CA, USA.
Fossum CC; Department of Radiation Oncology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
Farias A; Department of Preventative Medicine, Keck School of Medicine, University of Southern CA, Los Angeles, CA, USA.
Daneshmand S; Department of Urology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
Groshen S; Department of Preventative Medicine, Keck School of Medicine, University of Southern CA, Los Angeles, CA, USA.
Pokaż więcej
Źródło :
Cancer medicine [Cancer Med] 2021 May; Vol. 10 (9), pp. 3004-3012. Date of Electronic Publication: 2021 Mar 28.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms :
Organ Sparing Treatments*
Urinary Bladder*
Carcinoma, Transitional Cell/*mortality
Carcinoma, Transitional Cell/*therapy
Urinary Bladder Neoplasms/*mortality
Urinary Bladder Neoplasms/*therapy
African Continental Ancestry Group/statistics & numerical data ; Aged ; Carcinoma, Transitional Cell/pathology ; Combined Modality Therapy/mortality ; Combined Modality Therapy/statistics & numerical data ; Cystectomy/mortality ; Disease Progression ; European Continental Ancestry Group/statistics & numerical data ; Female ; Humans ; Kaplan-Meier Estimate ; Male ; Neoplasm Recurrence, Local ; Proportional Hazards Models ; Retrospective Studies ; Sex Factors ; Socioeconomic Factors ; Survival Analysis ; Time Factors ; Treatment Outcome ; Urinary Bladder Neoplasms/pathology
Czasopismo naukowe
Tytuł :
Sarcomatoid urothelial carcinoma of the bladder with osseous metaplasia: bone in urinary bladder.
Autorzy :
Varshney B; Pathology, All India Institute of Medical Sciences, Jodhpur, Rajasthan, India.
Choudhary GR; Urology, All India Institute of Medical Sciences, Jodhpur, Rajasthan, India.
Yadav T; Diagnostic and Interventional Radiology, All India Institute of Medical Sciences, Jodhpur, Rajasthan, India.
Nalwa A; Pathology, All India Institute of Medical Sciences, Jodhpur, Rajasthan, India .
Pokaż więcej
Źródło :
BMJ case reports [BMJ Case Rep] 2021 Apr 27; Vol. 14 (4). Date of Electronic Publication: 2021 Apr 27.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Bone Neoplasms*
Carcinoma, Transitional Cell*/surgery
Urinary Bladder Neoplasms*/drug therapy
Urinary Bladder Neoplasms*/surgery
Aged ; Cystectomy ; Humans ; Male ; Metaplasia ; Urinary Bladder/diagnostic imaging ; Urinary Bladder/surgery
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies